Dominion Energy Inc vs TransMedics Group Inc — how do they compare? Dominion Energy Inc trades at $68 (market cap $59.90B), while TransMedics Group Inc trades at $89.69 (market cap $3.10B). The key difference: Dominion Energy Inc is far larger — about 19.3× TransMedics Group Inc's market cap, and Dominion Energy Inc pays a 3.92% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| D | TMDX | |
|---|---|---|
Market Cap | $59.90B | $3.10B |
Sector | Utilities | Technology |
52-Week High | $71.67 | $150.42 |
52-Week Low | $57.08 | $61.99 |
Enterprise Value | $114.01B | $3.49B |
Dividend Yield | 3.92% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TMDX trades at $83.89, up 4.59% today, with a bullish technical signal from moving averages and strong support at $81. The company reported a Q2 2026 earnings miss ($0.44 actual vs. $0.50 expected) but beat revenue expectations, with 2025 net income at $190.29M. Analyst consensus is a Buy with a $99.57 price target, though recent news highlights a legal investigation into fiduciary duties.
Outlook remains positive due to raised revenue guidance and institutional interest, but risks include earnings volatility, margin pressure, and legal scrutiny. The stock's valuation multiples suggest growth expectations, yet execution on cost control and international expansion will be critical for sustained upside.
Trailing returns across standard periods
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →